AMI患者直接PCI术前后血清PICP、PⅢNP水平变化及意义被引量：1

下载PDF

导出

摘要采用ELISA法测定38例急性心肌梗死(AMI)患者直接经皮腔冠状动脉介入术(PCI)前,术后3、7、14、30 d血清Ⅰ型前胶原氨基端前肽(PⅠCP)、Ⅲ型前胶原氨基端末肽(PⅢNP)水平。结果血清PⅠCP、PⅢNP水平均于术后3 d达最高峰,之后渐回落,术后7 d接近术前水平。提示直接PCI术能减少AMI后心肌间质Ⅰ、Ⅲ胶原蛋白的合成,从而改善AMI后的心室重构。

作者孔敬博赵宗进高航

机构地区聊城市人民医院

出处《山东医药》 CAS 北大核心 2007年第29期57-58,共2页 Shandong Medical Journal

关键词急性心肌梗死经皮冠状动脉介入治疗心室重构

分类号 R542.2 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1Takemura G,Fujiwara H.Role of apoptosis in remodeling after myocardial infarction[J].Pharmacol Ther,2004,104(1):1-16.
2St John Sutton M,Ferrari VA.Prevention of Left Ventricular Remodeling After Myocardial Infarction[J].Curr Treat Options Cardiovasc Med,2002,4(2):97-108.
3黄斌雄.急性心肌梗死患者血浆Ⅲ型前胶原氨基末端肽含量的变化[J].临床心血管病杂志,2002,18(4):181-182. 被引量：3
4刘承云.血清Ⅰ、Ⅲ型前胶原端肽浓度在心血管疾病中的意义[J].国外医学（心血管疾病分册）,1997,24(4):18-20. 被引量：22
5耿传良,杨源,顾云,肖践明,曹晶茗,郭涛.择期经皮冠脉介入术对急性心肌梗死心肌微循环的作用[J].中国微循环,2006,10(2):86-88. 被引量：4
6谢萍,祝善俊.急性心肌梗死后心脏重塑及其临床意义[J].临床心血管病杂志,2002,18(9):476-479. 被引量：11
7Ponlsen SH,Host NB,Egstrup K.Long-term changes in collagen formation expressed by serum carboxyterminal propeptide of type-Ⅰ procollagen and relation to left ventricular function after acute myocardial infarction[J].Cardiology,2001,96(1):45-50.

二级参考文献25

1袁晓晨,刘乃丰,马根山,冯毅.糖尿病对冠状动脉介入治疗后心肌灌注的影响[J].中国微循环,2004,8(4):236-238. 被引量：2
2朱淑贤,钱菊英.冠状动脉微循环灌注障碍和冠脉无复流机理研究[J].微循环技术杂志（临床与实验）,2004,8(5):267-269. 被引量：17
3[1]Mahon N G, O'Roke, Codd M B, et al. Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart, 1999, 81:478-482.
4[2]Cohn J N, Roberto F, Norman S, et al. Cardiac remodeling-concepte and clinical implications:A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol, 2000, 35:569-582.
5[3]Givertz M M, Collucci W S. New targets for heart-failure therapy: Endothelin ,inflammatory cytokines, oxidative stress. Lancet, 1998, 352(Suppl I):34-38.
6[4]Yousef Z R, Redwood S R, Marber M S. Postinfarction left ventricular remodeling:Where are the theories and trials leading us? Heart, 2000, 83:76-80.
7[5]Vantrimpont P, Rouleau J L, Ciampi A, et al. Two-year course and significance of neurohumoral activation in the survival and ventricular enlargement (SAVE) study. Eur Heart J, 1998, 19:1552-1563.
8[6]Scheuer J. Catecholamines in cardiac hypertrophy. Am J Cardiol, 1999, 83:70-74H.
9[7]Collucci W S. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80: 15L-25L.
10[8]Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med, 1997, 336:1131-1141.